Z300 (Caprelsa 300 mg)
Generic Name: vandetanib
Pill with imprint Z300 is White, Elliptical/Oval and has been identified as Caprelsa 300 mg. It is supplied by Genzyme Corporation.
Caprelsa is used in the treatment of thyroid cancer and belongs to the drug classes EGFR inhibitors, multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Caprelsa 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Z300
Caprelsa
- Generic Name
- vandetanib
- Imprint
- Z300
- Strength
- 300 mg
- Color
- White
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- EGFR inhibitors, Multikinase inhibitors, VEGF/VEGFR inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Genzyme Corporation
- National Drug Code (NDC)
- 00310-7840 (Discontinued)
- Inactive Ingredients
-
calcium phosphate dihydrate dibasic,
microcrystalline cellulose,
povidone,
magnesium stearate,
hypromelloses,
titanium dioxide,
water,
polyethylene glycol 300
Note: Inactive ingredients may vary.
Related images for "Z300"
More about Caprelsa (vandetanib)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Drug images
- Pricing & coupons
- En español
- Drug class: EGFR inhibitors
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.